Sivan Weitzman
@Rivervest Venture Management Llc
Latest period2024 - Q3ReportedManaged Assets$6.838BTotal holdings3
Assets growth rate0.2%Assets growth rate (2-Q avg)-7.98%Continuous growth in asset value1 quarters
Portfolio positions
This chart displays the top 10 holdings in Rivervest Venture Management Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 3 positions.
Assets under management
The assets under management (AUM) of Rivervest Venture Management Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 6.838B in assets, with a quarterly growth rate of 0.2% and a 2-quarter average growth rate of -7.98%. The portfolio is managed by Sivan Weitzman, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
RPHMReneo Pharmaceuticals, Inc.
| 63.01% | $4.308B 2.534M shares@ $1700.0 avg price | |
SPRBSpruce Bioscience, Inc.
| 20.4% | $1.394B 2.936M shares@ $474.91 avg price | |
XLOXilio Therapeutics, Inc.
| 16.61% | $1.135B 1.441M shares@ $787.7 avg price |